[Preservation of the bladder in transitional cell tumors infiltrating the lamina propria].
Thirty-two patients with transitional cell cancer of the bladder infiltrating the lamina propria were treated with intravesical BCG. Seventy-five percent of these patients could keep their bladder at the cost of regular BCG treatment and strict endoscopic monitoring. A better evaluation of prognostic criteria, including malignancy grade, total amount of vesical muscle removed during the initial resection and investigation for lymphatic system emboli, should help in a better selection of patients, separating those who might have recurrent infiltrative tumours from those who would benefit from a conservative treatment and offering the former a more aggressive therapy.
Benoît
G
G
Service d'Urologie, Hôpital de Bicêtre, Université Paris-Sud.
Alexandre
L
L
Bensadoun
H
H
Vieillefond
A
A
Martin
P R
PR
Martin
A
A
Jardin
A
A
D000368:Aged; D000369:Aged, 80 and over; D001500:BCG Vaccine / Q000627:therapeutic use; D002295:Carcinoma, Transitional Cell / Q000473:pathology / Q000628:therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D012307:Risk Factors; D001749:Urinary Bladder Neoplasms / Q000473:pathology / Q000628:therapy*
D001500:BCG Vaccine
Préservation de la vessie dans les tumeurs paramalpighiennes infiltrant le chorion.